Lichen planus pemphigoides
Alerts and Notices
Important News & Links
Synopsis
LPP is usually idiopathic but has been associated with several medications, most commonly angiotensin-converting enzyme (ACE) inhibitors. Other implicated agents include Chinese herbs, cinnarizine, interferons, narrowband UVB, psoralen plus UVA (PUVA), ribavirin, simvastatin, and weight-reduction products.
Initially, patients present with lesions characteristic of LP: pink-to-violaceous, flat-topped, pruritic, polygonal papules and plaques that localize most commonly to flexural surfaces but may be widespread. Within months, tense vesicles and bullae develop on the LP lesions as well as on uninvolved skin, usually in an acral distribution. Concomitant onset of both conditions has also been described. Oral mucosal involvement is not uncommon.
The pathogenesis of LPP is not completely understood. However, it is thought that injury to basal keratinocytes exposes basement membrane and hemidesmosome antigens, such as BP180 and BP230, leading to autoantibody formation.
Codes
L43.8 – Other lichen planus
SNOMEDCT:
238653005 – Lichen planus pemphigoides
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Subscription Required
References
Subscription Required
Last Updated:06/18/2018